Smith R H, Babiuk L A, Stockdale P H
Infect Immun. 1981 Jan;31(1):129-35. doi: 10.1128/iai.31.1.129-135.1981.
A potassium thiocyanate (KSCN) extract of Pasteurella multocida serotype III:A was shown to protect mice from an intranasal challenge with up to 300 50% lethal doses of P. multocida. In addition to preventing death, bacteria were rapidly cleared from the lungs of immunized mice so that by 72 to 96 h postchallenge no bacteria were present in the lungs of immunized mice, whereas up to 10(9) bacteria were present in lungs of nonimmunized mice. Immunization by the intranasal route was slightly better than that by the intramuscular route. Protection was considered specific, since immunization with P. multocida protected only against P. multocida and not against Salmonella agona. Furthermore, a similar KSCN extract from P. haemolytica did not protect against P. multocida challenge. A comparison of the KSCN extract with a Formalin-killed bacterin suggested that the KSCN extract may be superior to the bacterin.
多杀性巴氏杆菌III:A型的硫氰酸钾(KSCN)提取物被证明可保护小鼠免受高达300个50%致死剂量的多杀性巴氏杆菌鼻内攻击。除了防止死亡外,免疫小鼠肺部的细菌也被迅速清除,以至于在攻击后72至96小时,免疫小鼠的肺部已无细菌,而未免疫小鼠的肺部则存在多达10⁹个细菌。经鼻途径免疫略优于经肌肉途径免疫。这种保护被认为具有特异性,因为用多杀性巴氏杆菌免疫仅对多杀性巴氏杆菌有保护作用,而对阿哥纳沙门氏菌无保护作用。此外,溶血巴氏杆菌的类似KSCN提取物对多杀性巴氏杆菌攻击没有保护作用。将KSCN提取物与福尔马林灭活菌苗进行比较表明,KSCN提取物可能优于菌苗。